626 Financial LLC Has $206,000 Position in The Clorox Company (NYSE:CLX)

626 Financial LLC lowered its position in The Clorox Company (NYSE:CLX) by 44.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,271 shares of the company’s stock after selling 1,000 shares during the quarter. 626 Financial LLC’s holdings in Clorox were worth $206,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new stake in Clorox in the third quarter valued at $27,000. Continuum Advisory LLC lifted its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP lifted its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox in the third quarter valued at $48,000. Finally, Friedenthal Financial acquired a new stake in Clorox in the third quarter valued at $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $158.95 on Wednesday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $19.67 billion, a P/E ratio of 55.38, a P/E/G ratio of 3.04 and a beta of 0.42. The company’s 50-day moving average price is $164.48 and its two-hundred day moving average price is $156.16.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the firm earned $0.49 EPS. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. On average, analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.07%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.03%.

Analysts Set New Price Targets

CLX has been the subject of a number of research reports. JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Barclays raised their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and raised their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $157.46.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.